SQA
BIO icon

Simon Quick Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Simon Quick Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-67
Closed -$35K – 439
2020
Q3 		$35K Sell
67
-150
-69% -$76K 0.01% 235
2020
Q2 		$98K Hold
217
– – 0.04% 123
2020
Q1 		$76K Buy
+217
New +$79.8K 0.03% 144

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Simon Quick Advisors's BIO Position: Q4 2020 in Review

Simon Quick Advisors sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2020, closing a stake of 67 shares — an estimated $35K sold.

Simon Quick Advisors first reported a position in BIO in Q1 2020 and held it in 3 quarters. The position peaked at $98K in Q2 2020. 491 funds tracked by Wall St. Rank hold BIO as of Q4 2020.

  • Simon Quick Advisors reported no remaining Bio-Rad Laboratories Class A position as of Q4 2020 after selling out during the quarter.
  • Simon Quick Advisors sold 67 Bio-Rad Laboratories Class A shares in Q4 2020, an estimated $35K.
  • Simon Quick Advisors first reported a position in Bio-Rad Laboratories Class A in Q1 2020 and held it in 3 quarters.
  • Simon Quick Advisors's Bio-Rad Laboratories Class A position peaked at $98K in Q2 2020.
  • 491 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2020.

Based on Simon Quick Advisors's 13F filing for Q4 2020, filed 27 Jan 2021.